Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice
This study provides valuable supplemental information to facilitate our understanding of the specific protective efficacy of CV-A16 VLPs and has significance for development of the candidate vaccine into a safe and effective vaccine.
Source: Archives of Virology - Category: Virology Source Type: research
More News: Child Development | Children | Hand, Foot and Mouth | Perinatology & Neonatology | Study | Vaccines | Virology